Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Glenview Capital Management

Investor type Hedge Fund
Founders Larry Robbins


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 8
Average round size
The average size of a deal this fund participated in
Portfolio companies 8
Rounds per year 0.35
Lead investments 1
Exits 3
Key employees 1

Areas of investment

  • Health Care
  • Medical
  • Medical Device
  • Personal Health
  • Solar

Glenview Capital Management appeared to be the VC, which was created in 2000. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.

The fund was created by Larry Robbins.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the Glenview Capital Management, startups are often financed by OPIC - Overseas Private Investment Corporation, Versant Ventures, THE WORLD BANK GROUP. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, RiverVest, Pequot Capital. In the next rounds fund is usually obtained by Skyline Ventures, InterWest Partners, Frazier Healthcare Partners.

The top amount of exits for fund were in 2011. The important activity for fund was in 2007. The common things for fund are deals in the range of more than 100 millions dollars. The fund is generally included in less than 2 deals every year.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Calypso Medical Among the most successful fund investment fields, there are Renewable Energy, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Glenview Capital Management:
Typical Co-investors
Glenview Capital Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Glenview Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
468 Capital -
ACE Investment Partners Ltd. Geneva, Geneve, Switzerland
Acorn Capital Australia, Melbourne, Victoria
Atain Farmington Hills, Michigan, United States
Avic Avionics Beijing, Beijing, China
Backs Group Japan, Kanagawa Prefecture, Kawasaki
Bharat Forge India, Maharashtra, Pune
BTM Japan, Tokyo
Ericsson-Deutsche Technology Fund Australia, New South Wales, Sydney
Foster & Foster Florida, Fort Myers, United States
Lifu Investment Management China, Guangdong, Guangzhou
No 8 Ventures -
PLS Venture Capital Partners France, Lyon, Rhone-Alpes
Ririshun Lejia Home Furnishing Trade China, Qingdao Shi, Shandong
SB Payment Service Japan, Tokyo
TASC Ventures Madison, United States, Wisconsin
Three Curve Capital Boston, Massachusetts, United States
Triodos Bank Germany -
Walloon -
We Ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Personal Health
15 Nov 2022 Guilford, Connecticut, United States


Health Care
$11M20 Oct 2022 Washington, District of Columbia, United States


Clinical Trials
Health Care
Medical Device
$245M23 Jun 2021 Stratford-on-Avon, England, United Kingdom

Quantum SI

Health Diagnostics
Life Science
$425M11 Jun 2021 Connecticut, United States

Health Care
$80M20 Apr 2021 Connecticut, United States

Butterfly Network

Health Care
Medical Device
Personal Health
$175M16 Feb 2021 Connecticut, United States


Renewable Energy
Wind Energy
$402M16 Jun 2015 Missouri City, Missouri, United States

Calypso Medical

Health Care
Medical Device
$42M08 Jan 2007 Seattle, Washington, United States
Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

– Quanta Dialysis Technologies announced that it has raised $245m in an oversubscribed and upsized Series D round.
– The round was led by Glenview Capital and co-led by Novo Holdings, with support from a broad group of other top-tier investors.
– Quanta’s award-winning portable hemodialysis system SC+ is the only next-generation system that delivers the performance and dose equivalence of larger, traditional dialysis systems—with on-demand dialysate production and high dialysate flow rates—while also offering the portability, digital connectivity and ease-of-use of a next-generation dialysis device.
– The funding will allow Quanta to accelerate its emergence as a significant force in this market.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Glenview Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: